Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients
about
sameAs
Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese populationPharmGKB summary: cyclosporine and tacrolimus pathwaysRelationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patientsClinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing.Pharmacokinetics of cyclosporin--a microemulsion in children with idiopathic nephrotic syndrome.Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.Association of CYP3A polymorphisms with the pharmacokinetics of cyclosporine A in early post-renal transplant recipients in China.Associations of ABCB1, NFKB1, CYP3A, and NR1I2 polymorphisms with cyclosporine trough concentrations in Chinese renal transplant recipients.Pharmacogenetics of drugs used in the treatment of ocular inflammatory diseases.Genes and beans: pharmacogenomics of renal transplant.The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation.Pharmacogenomic implications of population admixture: Brazil as a model case.Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies.The Effect of ABCB1 C3435T Polymorphism on Cyclosporine Dose Requirements in Kidney Transplant Recipients: A Meta-Analysis.Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations.Application of the F(ST) statistics to explore pharmacogenomic diversity in the Brazilian population.Global pharmacogenomics: distribution of CYP3A5 polymorphisms and phenotypes in the Brazilian population.CYP3A5 genotype, but not CYP3A4*1b, CYP3A4*22, or hematocrit, predicts tacrolimus dose requirements in Brazilian renal transplant patients.Weight of ABCB1 and POR genes on oral tacrolimus exposure in CYP3A5 nonexpressor pediatric patients with stable kidney transplant.Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients.
P2860
Q28083875-387598A8-3BCC-42F6-BB68-1F249110B6B6Q33989902-F75D62F1-5A86-4E72-B674-81683E0A442DQ34065305-FD116C05-3C34-4F29-AE27-D03EA7607DC9Q35782898-24C2CE45-276B-4CA9-A001-FCABC133D2DAQ36284830-6D72F68C-6651-4851-9BD4-FD1296852144Q37009025-E992ED86-430F-45F2-B6E1-917D0041C3DAQ37727173-B6B633D4-8E07-4FC1-AB02-5985EDED9583Q37728891-8293FC62-78E5-44D7-9DF3-C471288247B0Q38092131-1C8793C6-6169-4822-8282-ABB9640DDCB5Q38104742-E06BDB28-EFD0-4223-97E5-B98D4C6E4954Q38163945-600FE082-B208-4B14-8F17-B21E0101DF30Q38180220-ECC2DD5E-E167-4B8B-B082-B1A93D83FABFQ38247190-5052DE4D-6461-4809-B6F5-3A42FB020329Q38299085-FC15E669-2232-4429-8F73-3FCAFAE2112FQ38787174-60BE7A42-5849-4E95-A608-BB173B183F50Q39495836-E27B4DC5-B423-46BB-B72F-27DA6B1E623CQ41774099-B9329CA1-FDF3-4735-A18F-1A1C30ABBDF6Q44819549-67FB12CD-8D95-49AB-9BB6-8FC27189EB77Q47242677-39B13F35-3B0A-4CAE-9B6A-3A4F4AB4EDCFQ47741403-1CB735CD-A7DE-4827-B214-119BE22493F1
P2860
Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients
description
scientific article published on 01 August 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2011
@uk
name
Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients
@en
Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients
@nl
type
label
Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients
@en
Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients
@nl
prefLabel
Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients
@en
Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients
@nl
P2093
P2860
P50
P356
P1433
P1476
Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients
@en
P2093
Ana Santoro
Claudia R Felipe
Elida B Ojopi
Helio Tedesco-Silva
P2860
P304
P356
10.2217/PGS.11.70
P577
2011-08-01T00:00:00Z